LASSA FEVER
Clinical trials for LASSA FEVER explained in plain language.
Never miss a new study
Get alerted when new LASSA FEVER trials appear
Sign up with your email to follow new studies for LASSA FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine could stop deadly lassa fever
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing a new vaccine called LASSARAB, designed to protect against Lassa fever, a serious viral illness. The vaccine uses a modified rabies virus to deliver the Lassa antigen and includes an adjuvant to boost the immune response. 55 healthy adults will r…
Matched conditions: LASSA FEVER
Phase: PHASE1 • Sponsor: Wilbur Chen, MD, MS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
Experimental IV drug targets deadly fevers in military personnel
Disease control TerminatedThis trial investigates whether intravenous ribavirin can help treat people with Crimean-Congo hemorrhagic fever or Lassa fever, two severe viral infections. The study enrolls up to 30 military-affiliated adults who have a probable or suspected case. Participants receive a specif…
Matched conditions: LASSA FEVER
Phase: NA • Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New oral drug shows promise against deadly lassa fever in west africa trial
Disease control TerminatedThis study tests a new oral antiviral drug, ARN-75039, for treating Lassa fever, a serious viral illness common in West Africa. About 135 hospitalized adults will receive either a high or low dose of the new drug or the standard IV treatment, ribavirin, for 10 days. The goal is t…
Matched conditions: LASSA FEVER
Phase: PHASE2 • Sponsor: Arisan Therapeutics, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC